Clinical trial

Study of ASN003 in Subjects With Advanced Solid Tumors

NCT02961283

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention ASN003 ascending doses Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention ASN003 MTD Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of ASN003 in Subjects With Advanced Solid Tumors

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2016-10-01

PhasePHASE1

Conditions

Neoplasmsunresolved

Melanomaverified · MONDO: melanoma

Colorectal Neoplasmverified · MONDO: colorectal neoplasm

Carcinoma, Non-small Cell Lungcandidate · MONDO: non-small cell lung carcinoma

Interventions

ASN003 ascending dosesDRUG

ASN003 MTDDRUG

Sponsors & collaborators

Asana BioScienceslead sponsor

Mapped research locations

BostonMassachusetts, United States1 Los AngelesCalifornia, United States1 San AntonioTexas, United States1 TampaFlorida, United States1 Grand RapidsMichigan, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02961283 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.